# | Name | Compound Key | Action Type | Relation | Activity Value | Units | Assay ID | Assay Description | Comment | Assay | Assay Organism | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
1. | ALA4460170 | 96 | Activity | = | 20 | % | ALA4397139 | % | Human immunodeficiency virus type 1 group M subtype B (isolate HXB2)(HIV-1) | |||
2. | ALA4460170 | 96 | FC | = | 2 | ALA4397132 | Human immunodeficiency virus type 1 group M subtype B (isolate HXB2)(HIV-1) | |||||
3. | ALA4460170 | 96 | EC50 | = | 6.3 | uM | ALA4397106 | 5.20 | nM | |||
4. | ALA4460170 | 96 | EC50 | = | 11 | uM | ALA4397105 | 4.96 | nM | Human immunodeficiency virus type 1 group M subtype B (isolate HXB2)(HIV-1) | ||
5. | ALA4460170 | 96 | Activity | = | 26 | % | ALA4397099 | % | Human immunodeficiency virus type 1 group M subtype B (isolate HXB2)(HIV-1) | |||
6. | ALA4460170 | 96 | CC50 | > | 20 | uM | ALA4397096 | nM | Homo sapiens | |||
7. | ALA4460170 | 96 | CC50 | = | 1.5 | uM | ALA4397095 | nM | Homo sapiens | |||
8. | ALA4460170 | 96 | CLH | = | 56 | microL/min/mg | ALA4397094 | mL.min-1.g-1 | ||||
9. | ALA4460170 | 96 | t1/2 | = | 31 | min | ALA4397093 | hr | ||||
10. | ALA4460170 | 96 | CLH | = | 22 | microL/min/mg | ALA4397092 | mL.min-1.g-1 | ||||
11. | ALA4460170 | 96 | t1/2 | = | 80 | min | ALA4397091 | hr | ||||
12. | ALA4460170 | 96 | solubility | < | 1.6 | uM | ALA4397090 | nM | ||||
13. | ALA4460170 | 96 | solubility | < | 1.6 | uM | ALA4397089 | nM | ||||
14. | ALA4460170 | 96 | EC50 | = | 5.7 | uM | ALA4397085 | 5.24 | nM | Homo sapiens | ||
15. | ALA4460170 | 96 | EC50 | = | 3.1 | uM | ALA4397086 | 5.51 | nM | Human immunodeficiency virus type 1 group M subtype B (isolate HXB2)(HIV-1) |